Pure Global
NCT05319522

The Relationship Between Irisin and Bone Health in Individuals With Spinal Cord Injury

The Influence of Irisin/FNDC5 on Bone Mineral Density and Fracture Risk in Individuals With Spinal Cord Injury
VA Office of Research and Development·ClinicalTrials.gov·behavioralNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Spinal Cord Injury
Drug/Device/Intervention
Acute Exercise
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
VA Office of Research and Development
Location
Pittsburgh, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jan 02, 2023
End date
Dec 01, 2023
Enrollment
44 participants
Primary outcome

Irisin - Bone measure correlations,FNDC5 gene expression,Exercise induced change in irisin concentration

Summary

This study will examine the relationship between circulating irisin and bone health
 individuals with spinal cord injury. Additionally, this study seeks to examine the influence
 of muscle fiber type on circulating irisin and identify an exercise-based means to increase
 irisin concentrations.

ICD-10 classifications
Sequelae of injury of spinal cordOther injury of lumbar spinal cordInjury of spinal cord, level unspecifiedOther and unspecified injuries of thoracic spinal cordOther and unspecified injuries of cervical spinal cord
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05319522
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05319522 through Pure Global AI's free database. This phase not specified trial is sponsored by VA Office of Research and Development and is currently Not yet recruiting. The study focuses on Spinal Cord Injury. Target enrollment is 44 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.